Apotex Inc. is recalling a specific lot of Acyclovir Tablets USP 800 mg because some tablets may contain pieces of nitrile rubber glove embedded within them. This recall affects 4,844 bottles distributed nationwide and in Puerto Rico. The product was manufactured for Apotex Corp. in Weston, Florida. Read more at govinfonow.com/recall/46844-apotex-inc-recalls-acyclovir-tablets-usp-800-mg-ndc-60505.
“Apotex Recalls Acyclovir Tablets Due to Rubber Particles.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46844-apotex-inc-recalls-acyclovir-tablets-usp-800-mg-ndc-60505. Based on FDA recall #D-017-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-017-2014%22&limit=1).
The FDA announced on July 17, 2013, that Apotex Inc. is recalling Acyclovir Tablets USP 800 mg due to the presence of particulate matter. The Class II recall affects lot KF2199 distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Apotex
Product: Acyclovir Tablets 800 mg
NDC: 60505-5307-1
Lot code: KF2199
Expiration date: 07/15
Quantity: 4,844 bottles
The hazard
The record states that product from lot KF2199 may contain tablets with pieces of nitrile rubber glove embedded within the tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Apotex Inc. has 19 other recalls on record since April 30, 2012. Other recent recalls of similar products include Apotex Metformin Tablets Recall (May 27, 2020) and Apotex Atorvastatin 40mg Tablets Recall (Oct. 22, 2019). Amneal recalled Primidone Tablets on June 3, 2026, due to cross-contamination risk. Apotex recalled Paxil CR 37.5mg Tablets on Aug. 13, 2026, for failed stability testing.
How to tell if you have this one
Check your medication bottle for NDC 60505-5307-1 and Lot number KF2199. The expiration date on the label is Exp 07/15. The product is Rx only and manufactured by Apotex Inc. in Toronto, Ontario, Canada.
Brand
Apotex
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop taking the medication
Do not consume any tablets from the recalled lot KF2199 due to the risk of ingesting rubber particles.
Contact your pharmacist or doctor
Reach out to your healthcare provider or pharmacy immediately to discuss alternative treatment options and proper disposal.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 13 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-017-2014 (July 17, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-017-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.